These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 2863192)

  • 1. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
    Hayward NJ; Harding M; Lloyd SA; McKnight AT; Hughes J; Woodruff GN
    Br J Pharmacol; 1991 Dec; 104(4):973-7. PubMed ID: 1687371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Nagaya H; Inatomi N; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-365,260, a potent CCK-B/gastrin receptor antagonist, suppresses gastric acid secretion induced by histamine and bethanechol as well as pentagastrin in rats.
    Nishida A; Yuki H; Tsutsumi R; Miyata K; Kamato T; Ito H; Yamano M; Honda K
    Jpn J Pharmacol; 1992 Feb; 58(2):137-45. PubMed ID: 1354760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of dibutyryl cyclic guanosine monophosphate, a competitive antagonist to cholecystokinin-pancreozymin, on gastric acid secretion in the isolated mouse stomach.
    Davison JS; Najafi-Farashah A
    Life Sci; 1982 Jul; 31(4):355-61. PubMed ID: 6128663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cholecystokinin in pancreatic exocrine response to intraluminal amino acids and fat.
    Stubbs RS; Stabile BE
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G347-52. PubMed ID: 2858160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
    Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
    Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastrin- and histamine-stimulated gastric acid secretion by gastrin and cholecystokinin antagonists in the rat.
    Hirst BH; Elliott KJ; Ryder H; Szelke M
    Aliment Pharmacol Ther; 1991 Feb; 5(1):31-9. PubMed ID: 1932479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various gastrointestinal peptides on parietal cells and endocrine cells in the oxyntic mucosa of rat stomach.
    El Munshid HA; Håkanson R; Liedberg G; Sundler F
    J Physiol; 1980 Aug; 305():249-65. PubMed ID: 6108365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endogenous secretin and cholecystokinin in intraduodenal oleic acid-induced inhibition of gastric acid secretion in rats.
    Shiratori K; Watanabe S; Takeuchi T
    Dig Dis Sci; 1992 Mar; 37(3):397-402. PubMed ID: 1735364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin receptor antagonism of stimulated pancreatic and gastric secretion.
    Mulholland MW; Debas HT
    J Surg Res; 1989 Nov; 47(5):460-4. PubMed ID: 2478762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cholecystokinin in canine pancreatic exocrine response to bombesin stimulation.
    Nealon WH; Beauchamp RD; Townsend CM; Thompson JC
    Am J Surg; 1987 Jan; 153(1):96-101. PubMed ID: 3799899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretagogue-specific effects of interleukin-1 on gastric acid secretion.
    Wallace JL; Cucala M; Mugridge K; Parente L
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G559-64. PubMed ID: 1681735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective action of a CCK-B/gastrin receptor antagonist, S-0509, on pentagastrin-, peptone meal- and beer-stimulated gastric acid secretion in dogs.
    Sasaki N; Matsuno K; Okabe S
    Aliment Pharmacol Ther; 2000 Apr; 14(4):479-88. PubMed ID: 10759628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
    Hills DM; Gerskowitch VP; Roberts SP; Welsh NJ; Shankley NP; Black JW
    Br J Pharmacol; 1996 Dec; 119(7):1401-10. PubMed ID: 8968549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of in vivo acid secretory responses of rabbit with comparison to dog and rat.
    Mulvihill SJ; Pappas TN; Debas HT
    Dig Dis Sci; 1989 Jun; 34(6):895-904. PubMed ID: 2566457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release.
    Gerber JG; Payne NA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):718-23. PubMed ID: 8930176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.